Oral Biologics for Cardiometabolic Diseases (Lumen Bioscience / Novo Nordisk) is Drug Discovery in United States that focus on Provider business. Founded in 2021. They cover business area such as Provider, research and development service, novel strategy, oral biologic, cardiometabolic disease.
2021
( 3 years old in 2024 )
Provider
-
1441 North 34th Street
Suite 300
Seattle, WA 98103
United States
Private
Providerresearch and development servicenovel strategyoral biologiccardiometabolic disease
* We use standard office opening hours in near Oral Biologics for Cardiometabolic Diseases (Lumen Bioscience / Novo Nordisk)'s location as default value for unknown and outdated data. For more valid info, please verify the info from more trusted sources like GoogleMyBusiness, Yelp, FourSquare or similar services.
Oral Biologics For Cardiometabolic Diseases (Lumen Bioscience / Novo Nordisk) is Drug Discovery business from United States that founded in 2021 (3 years old in 2024), Oral Biologics for Cardiometabolic Diseases (Lumen Bioscience / Novo Nordisk) business is focusing on Provider.
Oral Biologics for Cardiometabolic Diseases (Lumen Bioscience / Novo Nordisk) headquarter office and corporate office address is located in 1441 North 34th Street Suite 300 Seattle, WA 98103 United States.
Oral Biologics for Cardiometabolic Diseases (Lumen Bioscience / Novo Nordisk) was founded in United States.
In 2024, Oral Biologics for Cardiometabolic Diseases (Lumen Bioscience / Novo Nordisk) is currently focus on Provider sector.
Above is snippet of Google Trends for "Provider" term, if you have problem loading the snippet, please visit here: Google Trend.
Disclaimer: This website is not affiliated with Oral Biologics for Cardiometabolic Diseases (Lumen Bioscience / Novo Nordisk), any government agency, does not create this data, vouch for its accuracy, or guarantee that it is the most recent data available. The data displayed is available through open government websites and public online directory. This website expressly disclaims the accuracy, adequacy, or completeness of any data and shall not be liable for any errors, omissions or other defects in, delays or interruptions in such data, or for any actions taken in reliance thereon.
